October 12th, 2026Rosacea Likely Underdiagnosed in Patients With Skin of ColorRosacea is likely missed, not rare, in skin of color, as low suspicion and hard-to-see redness delay diagnosis, said Hilary Baldwin, MD.Read more
October 12th, 2026Early HS Treatment May Prevent Scarring in Patients With Skin of ColorHidradenitis suppurativa diagnosis often takes 7 to 10 years, and patients with skin of color often present with tunnels and scarring already in place.Read more
October 12th, 2026New Mechanism of DME Treatment Highlights Clinical Trial UpdatesThe conference session featured updates on several clinical trials, including the BRUNELLO trial, for treatment of diabetic macular edema (DME).Read more
October 11th, 2026Using Complement Inhibitors in GA Comes With Pros and ConsPanelists engaged in a debate regarding using complement inhibitors in geographic atrophy, gauging public sentiment with a deciding vote.Read more
October 11th, 2026Big Data, MIGS Are Crucial Areas of Glaucoma Treatment: AAO PanelA session at AAO 2026 highlighted how big data and minimally invasive glaucoma surgery (MIGS) could be utilized to help patients receive peak care.Read more
October 10th, 2026Medicaid Expansion Associated With Lower Colorectal Cancer MortalityMedicaid expansion was associated with lower colorectal cancer mortality, with the largest reductions in Hispanic patients and stage IV disease.Read more
October 8th, 2026Heat Deaths Highest Among Military, Farm, ConstructionA JAMA analysis of 2021-2023 death records found heat-related mortality varied sharply by occupation and industry among working-age US adults.Read more
October 7th, 2026As Mantle Cell Lymphoma Risk Tools Advance, Access Lags BehindBiomarker-driven care is advancing in mantle cell lymphoma, though cost and infrastructure limit access in community oncology, according to a review.Read more